Showing results (11-20 of 268) with videos related to
Sort By:
Pageof 27
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1991
N-(p-isothiocyanatophenethyl)spiperone, a selective and irreversible antagonist of D2 dopamine receptors in brainS X Xu, Y Hatada, L E Black, et al.Neuroscience Letters|October 29, 1993
Antisense oligodeoxynucleotide reduces brain dopamine D2 receptors: behavioral correlatesM Zhang, I CreeseBiochemical Pharmacology|May 9, 1997
Differential regulation of expression of rat hippocampal muscarinic receptor subtypes following fimbria-fornix lesionZ Zang, I CreeseAnnual Review of Pharmacology and Toxicology|May 20, 1999
New insights into dopaminergic receptor function using antisense and genetically altered animalsD R SibleyMolecular Pharmacology|April 1, 1986
Characterization of alpha 1-adrenergic receptor subtypes in rat brain: a reevaluation of [3H]WB4104 and [3H]prazosin bindingA L Morrow, I CreeseMolecular Pharmacology|August 1, 1986
Effects of in vivo and in vitro treatments with N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline on putative muscarinic receptor subtypes in rat brainA B Norman, I CreeseMolecular Pharmacology|January 1, 1982
Phenoxybenzamine treatment differentiates dopaminergic 3H-ligand binding sites in bovine caudate membranesM W Hamblin, I CreeseThe Journal of Pharmacology and Experimental Therapeutics|July 1, 1975
Receptor binding and pharmacological activity of opiates in the guinea-pig intestineI Creese, S H SnyderBrain Research|January 17, 1975
The pharmacological and anatomical substrates of the amphetamine response in the ratI Creese, S D IversenPharmacology, Biochemistry, and Behavior|February 13, 2001
Intra-accumbens infusion of D(3) receptor agonists reduces spontaneous and dopamine-induced locomotionA M Ouagazzal, I CreesePageof 27